Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  



Asthma lawsuits: Glaxo and Serevent & Advair

The May 8 Forbes prints my letter critical of their earlier story on Serevent/Advair litigation. Press coverage of the Forbes story is being criticized for causing undue panic. (Liv Osby, "Advair story causes alarm among some asthma sufferers", Greeneville News, Apr. 7).



Isaac Gorodetski
Project Manager,
Center for Legal Policy at the
Manhattan Institute

Katherine Lazarski
Press Officer,
Manhattan Institute


Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.